Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1995 7
1996 9
1997 9
1998 7
1999 10
2000 10
2001 9
2002 13
2003 17
2004 15
2005 28
2006 15
2007 14
2008 17
2009 23
2010 21
2011 31
2012 30
2013 43
2014 47
2015 42
2016 42
2017 35
2018 39
2019 35
2020 40
2021 47
2022 45
2023 46
2024 20

Text availability

Article attribute

Article type

Publication date

Search Results

653 results

Results by year

Filters applied: . Clear all
Page 1
ANCA-Associated Vasculitis: Core Curriculum 2020.
Geetha D, Jefferson JA. Geetha D, et al. Am J Kidney Dis. 2020 Jan;75(1):124-137. doi: 10.1053/j.ajkd.2019.04.031. Epub 2019 Jul 26. Am J Kidney Dis. 2020. PMID: 31358311 Review.
Randomized controlled trials in the past 2 decades have refined the therapy of AAV and transformed AAV from a fatal disease to a chronic illness with relapsing course and associated morbidity. This article in AJKD's Core Curriculum in Nephrology series provides a detailed …
Randomized controlled trials in the past 2 decades have refined the therapy of AAV and transformed AAV from a fatal disease to a chronic ill …
Immunopathogenesis of ANCA-Associated Vasculitis.
Kronbichler A, Lee KH, Denicolò S, Choi D, Lee H, Ahn D, Kim KH, Lee JH, Kim H, Hwang M, Jung SW, Lee C, Lee H, Sung H, Lee D, Hwang J, Kim S, Hwang I, Kim DY, Kim HJ, Cho G, Cho Y, Kim D, Choi M, Park J, Park J, Tizaoui K, Li H, Smith L, Koyanagi A, Jacob L, Gauckler P, Shin JI. Kronbichler A, et al. Int J Mol Sci. 2020 Oct 3;21(19):7319. doi: 10.3390/ijms21197319. Int J Mol Sci. 2020. PMID: 33023023 Free PMC article. Review.
Recent research provided evidence that genetic background, risk of relapse, prognosis, and co-morbidities are more closely related to the ANCA serotype, proteinase 3 (PR3)-ANCA and myeloperoxidase (MPO)-ANCA, compared to the disease phenotypes GPA or MPA. This finding has …
Recent research provided evidence that genetic background, risk of relapse, prognosis, and co-morbidities are more closely related to …
Interstital lung disease in ANCA vasculitis.
Alba MA, Flores-Suárez LF, Henderson AG, Xiao H, Hu P, Nachman PH, Falk RJ, Charles Jennette J. Alba MA, et al. Autoimmun Rev. 2017 Jul;16(7):722-729. doi: 10.1016/j.autrev.2017.05.008. Epub 2017 May 4. Autoimmun Rev. 2017. PMID: 28479484 Free PMC article. Review.
More importantly, these studies have shown that ILD has an adverse impact on the long-term prognosis of ANCA vasculitis. This review focuses on the main clinical and radiologic features of pulmonary fibrosis associated with anti-neutrophil cytoplasmic antibodies. Major his …
More importantly, these studies have shown that ILD has an adverse impact on the long-term prognosis of ANCA vasculitis. This review …
ANCA-associated vasculitis-treatment standard.
Chalkia A, Jayne D. Chalkia A, et al. Nephrol Dial Transplant. 2024 May 31;39(6):944-955. doi: 10.1093/ndt/gfad237. Nephrol Dial Transplant. 2024. PMID: 37947275 Review.
Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis.
Sebastiani M, Manfredi A, Vacchi C, Cassone G, Faverio P, Cavazza A, Sverzellati N, Salvarani C, Luppi F. Sebastiani M, et al. Clin Exp Rheumatol. 2020 Mar-Apr;38 Suppl 124(2):221-231. Epub 2020 Apr 22. Clin Exp Rheumatol. 2020. PMID: 32324122 Free article. Review.
In this review, we discuss the available evidence on clinical features, diagnostic work-up, prognosis and management of AAV-ILD....
In this review, we discuss the available evidence on clinical features, diagnostic work-up, prognosis and management of AAV-ILD....
Polyarteritis nodosa: an evolving primary systemic vasculitis.
Springer JM, Byram K. Springer JM, et al. Postgrad Med. 2023 Jan;135(sup1):61-68. doi: 10.1080/00325481.2022.2088940. Epub 2022 Jun 22. Postgrad Med. 2023. PMID: 35709399 Review.
Treatment of systemic primary PAN involves the use of systemic immunosuppressive therapy largely guided by the severity of disease. With current treatment regimens, the prognosis has changed from a once uniformly fatal disease to a 5-year survival rate above 80%....
Treatment of systemic primary PAN involves the use of systemic immunosuppressive therapy largely guided by the severity of disease. With cur …
The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort.
Guillevin L, Pagnoux C, Seror R, Mahr A, Mouthon L, Toumelin PL; French Vasculitis Study Group (FVSG). Guillevin L, et al. Medicine (Baltimore). 2011 Jan;90(1):19-27. doi: 10.1097/MD.0b013e318205a4c6. Medicine (Baltimore). 2011. PMID: 21200183 Free article.

According to the 2009 FFS, 5-year mortality rates for scores of 0, 1, and 2 were 9%, 21% (p < 0.005), and 40% (p < 0.0001), respectively.The revised FFS for the 4 systemic necrotizing vasculitides now comprises 4 factors associated with poorer prognosis and 1 with be

…

According to the 2009 FFS, 5-year mortality rates for scores of 0, 1, and 2 were 9%, 21% (p < 0.005), and 40% (p < 0.0001), respective

…
Polyarteritis nodosa revisited: a review of historical approaches, subphenotypes and a research agenda.
Karadag O, Jayne DJ. Karadag O, et al. Clin Exp Rheumatol. 2018 Mar-Apr;36 Suppl 111(2):135-142. Epub 2018 Feb 20. Clin Exp Rheumatol. 2018. PMID: 29465365 Free article. Review.
Polyarteritis nodosa (PAN) is a rare form of primary systemic vasculitis with heterogeneous presentations, treatments and disease course. Historical approaches to classification and diagnostic terminology are reviewed. ...
Polyarteritis nodosa (PAN) is a rare form of primary systemic vasculitis with heterogeneous presentations, treatments and disease course …
Long-term outcomes and prognostic factors for survival of patients with ANCA-associated vasculitis.
Sánchez Álamo B, Moi L, Bajema I, Faurschou M, Flossmann O, Hauser T, Hruskova Z, Jayne D, Luqmani R, Mahr A, Åkesson A, Westman K; EUVAS. Sánchez Álamo B, et al. Nephrol Dial Transplant. 2023 Jun 30;38(7):1655-1665. doi: 10.1093/ndt/gfac320. Nephrol Dial Transplant. 2023. PMID: 36617233
Demographic, clinical and laboratory characteristics at trial entry were studied as potential prognostic factors in multivariable models. RESULTS: A total of 478 (56%) patients had granulomatosis with polyangiitis (GPA) and 370 (44%) had microscopic polyangiitis (MPA) with …
Demographic, clinical and laboratory characteristics at trial entry were studied as potential prognostic factors in multivariable mod …
Monitoring disease activity in antineutrophil antibody-associated vasculitis.
Scurt FG, Hirschfeld V, Schubert L, Mertens PR, Chatzikyrkou C. Scurt FG, et al. Scand J Immunol. 2023 Jul;98(1):e13284. doi: 10.1111/sji.13284. Epub 2023 May 11. Scand J Immunol. 2023. PMID: 37132459 Review.
Despite the simplification of treatment, fundamental aspects concerning assessment of its efficacy and its adaptation to encountered complications or to the relapsing/remitting/subclinical disease course remain still unknown. Through the advances in pathogenesis and pathop …
Despite the simplification of treatment, fundamental aspects concerning assessment of its efficacy and its adaptation to encountered complic …
653 results